FCGBP and inflammatory bowel disease: Based on this unique interaction, FCGBP-MUC2 binding is probably destabilized in the gut by different pH levels and reducing agents similar to the conditions that occur in acute/chronic inflammation in infectious and inflammatory bowel disease (55, 56).